The European Drug Report 2024 provides a comprehensive overview of drug use in Europe. It covers a wide range of topics, including prevalence, treatment, harm reduction, drug production, supply, and seizures.

The report finds that cannabis is the most commonly used illicit drug in Europe, followed by cocaine. New psychoactive substances (NPS) are an emerging concern, with new drugs appearing on the market all the time.

The report also highlights the challenges of responding to drug use in Europe. These challenges include the globalisation of the drug market, the increasing potency of drugs, and the emergence of new drugs.

In order to effectively address these challenges, the report calls for a comprehensive and balanced approach to drug policy. This approach should include measures to prevent drug use, reduce the harms caused by drug use, and provide treatment for people with drug use disorders.

Key Findings

Here is a more detailed look at some of the key findings of the report:

• Cannabis: Cannabis is the most commonly used illicit drug in Europe, with an estimated 83.7 million adults (aged 18-64) having used it in their lifetime. Cannabis use is highest in Western and Central Europe.
• Cocaine: Cocaine is the second most commonly used illicit drug in Europe, with an estimated 18.9 million adults having used it in their lifetime. Cocaine use is highest in Western and Southern Europe.
• New psychoactive substances (NPS): NPS are a growing concern in Europe. There are currently over 800 NPS monitored by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). NPS can be very dangerous, as they often have unknown effects.
• Drug production: The production of illicit drugs in Europe is a significant problem. Europe is a major producer of cannabis, MDMA, and amphetamines.
• Drug supply: The drug supply in Europe is complex and constantly changing. Drugs are trafficked into Europe from all over the world.
• Drug seizures: Law enforcement agencies in Europe seize a large quantity of drugs every year. However, drug seizures do not appear to be having a major impact on the availability of drugs.

The European Drug Report 2024 is a valuable resource for anyone interested in learning more about drug use in Europe. The report provides a comprehensive overview of the current situation and highlights the challenges that need to be addressed.

Source

EUDA